Intellectual Proprety Archives - Page 4 of 4

Jul 10, 2014

The first Middle East and North Africa Community Advisory Board (MENA-CAB)

Advocacy, AIDS, Algeria, ARV, Daclatasvir, Dolutegravir, Guidelines, HIV, Intellectual Proprety, Libya, Middle East, Morocco, North Africa, REGION, Tunisia 11 Views

Casablanca, Morocco, 28 June-01 July 2014 Despite the fact that HIV prevalence in the countries of the Middle East and North Africa is believed to be low at least among the General Population,Read More

Feb 28, 2014

Pharma Refuses to Ensure Access to Lifesaving Hepatitis C Treatment at Global Meeting

Advocacy, ARV, HCV, Health Financing, Hepatitis, Intellectual Proprety, Medias 14 Views

Bangkok, Thailand, February 28, 2014 —Thirty-eight activists from 22 countries joined forces at the first-ever Hepatitis C Virus (HCV) World Community Advisory Board (CAB) to demand equitable access to treatment for hepatitis CRead More